Historial de carrera de Ingmar Bruns
Antiguos cargos conocidos de Ingmar Bruns.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Director Técnico/Científico/I+D | 02/11/2020 | 17/11/2021 |
| PIERIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 12/10/2017 | - |
Formación de Ingmar Bruns.
| Universität zu Lübeck | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 2 |
| Alemania | 2 |
| Canadá | 2 |
Operativa
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Ingmar Bruns
- Experiencia
